Fusion interface stress and its potential effect on microcrack in 10-kW level laser welding

2022 ◽  
Vol 128 (2) ◽  
Author(s):  
Youmin Rong ◽  
Youzhi Li ◽  
Lu Wang ◽  
Jiajun Xu ◽  
Yu Huang
Keyword(s):  
Laser Welding ◽  
Potential Effect ◽  
Interface Stress ◽  
Level Laser

30 kW-level laser welding characteristics of 5A06 aluminum alloy thick plate under subatmospheric pressure

2019 ◽  
Vol 119 ◽  
pp. 105668 ◽  
Author(s):  
Jiming Wang ◽  
Genchen Peng ◽  
Liqun Li ◽  
Changjian Si ◽  
Shenghao Meng ◽  
...  
Keyword(s):  
Aluminum Alloy ◽  
Laser Welding ◽  
Thick Plate ◽  
Subatmospheric Pressure ◽  
Level Laser ◽  
5A06 Aluminum Alloy

Strength characterization of assemblies of polymers, made by laser welding

2015 ◽  
Vol 103 (5) ◽  
pp. 503
Author(s):  
Vladimir Gantchenko ◽  
Jacques Renard ◽  
Alexander Olowinsky ◽  
Gerhard Otto
Keyword(s):  
Laser Welding ◽  
Strength Characterization

Peculiarities of laser welding of Chromium-Nickel steel and Titanium alloy

2019 ◽  
Author(s):  
Ekaterina Senaeva ◽  
◽  
Nataliya Pugacheva ◽  
Aleksei Makarov ◽  
◽  
...  
Keyword(s):  
Titanium Alloy ◽  
Laser Welding ◽  
Nickel Steel

Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers

2020 ◽  
pp. 82-94
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Pharmaceutical Care ◽  
Biochemical Parameters ◽  
Positive Impact ◽  
Potential Effect ◽  
Care Group ◽  
Mineral Bone Disorder ◽  
Bone Disorder

Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters. Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters. Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL.

Assessment of healing of dental implant surgical site following Low-Level Laser Therapy using Bio-Clinical parameters: An Exploratory Study

2020 ◽  
Author(s):  
VARSHA PALLED ◽  
DR. JITENDRA RAO ◽  
DR. RAGHUWAR DAYAL SINGH ◽  
DR. SHUCHI TRIPATHI ◽  
DR. KALPANA SINGH ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Test Group ◽  
Low Level Laser Therapy ◽  
Control Group ◽  
Clinical Parameters ◽  
Implant Stability ◽  
Low Level ◽  
Implant Stability Quotient ◽  
Low Level Laser ◽  
Level Laser

The purpose of this study was to evaluate whether Low-Level Laser Therapy (LLLT) improves the healing of the implant surgical site with clinical and biochemical parameters.Thirty patients with an edentulous space spanning a single tooth were selected. The patients were randomly allocated to two groups - the control group and the test group. The test group received laser energy at a power of 2J/cm 2 with a total of 4-6J energy over each implant. Clinical parameters (Implant Stability Quotient, probing index, modified sulcus bleeding index)and osteoprotegerin (OPG) were assessed at baseline and follow-up intervals (2 weeks, 6 weeks, and 3 months).The test group showed significantly higher implant stability quotient compared to thecontrol group at 2 weeks(57.93±3.95 and 35.67±3.08; p<0.01) and 3months(58.86±3.75 and 67.06±3.78; p<0.01). A significant rise in OPG levels of the test group(686.30±125.36pg/ml at baseline and 784.25±108.30pg/ml at 3months;p<0.01) was seen contrary to significant decline in the control group (839.50±249.08pg/ml at baseline,415.30±78.39pg/ml at 3months;p<0.01). Within the limitations of the study, the study suggests that the healing of peri-implant hard and soft tissues may be enhanced with the use of LLLT as an explicit modality during the post-operative period.

Sign in / Sign up

Export Citation Format

Share Document